FAM19A5 in vascular aging and osteoporosis: Mechanisms and the "calcification paradox"

被引：0
|
作者：
Zheng, Jin [1 ]
He, Jieyu [2 ]
Li, Huahua [1 ,3 ]
机构：
[1] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Geriatr, Affiliated Hosp 1, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Geriatr, Changsha, Hunan, Peoples R China
[3] Hunan Normal Univ, Hunan Prov People symbolscript Hosp, Dept Geriatr, Affiliated Hosp 1, Changsha 410005, Hunan, Peoples R China
来源：
AGEING RESEARCH REVIEWS | 2024年 / 99卷
关键词：
Vascular aging; Vascular smooth muscle cells; Osteoporosis; Tumor; SMOOTH-MUSCLE-CELLS; BONE-MINERAL DENSITY; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; NEUROVASCULAR UNIT; RANKL; EXPRESSION; OSTEOPROTEGERIN;
D O I：
10.1016/j.arr.2024.102361
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Aging induces a progressive decline in the vasculature's structure and function. Vascular aging is a determinant factor for vascular ailments in the elderly. FAM19A5, a recently identified adipokine, has demonstrated involvement in multiple vascular aging-related pathologies, including atherosclerosis, cardio-cerebral vascular diseases and cognitive deficits. This review summarizes the current understanding of FAM19A5' role and explores its putative regulatory mechanisms in various aging-related disorders, including cardiovascular diseases (CVDs), metabolic diseases, neurodegenerative diseases and malignancies. Importantly, we provide novel insights into the underlying therapeutic value of FAM19A5 in osteoporosis. Finally, we outline future perspectives on the diagnostic and therapeutic potential of FAM19A5 in vascular aging-related diseases.
引用
收藏
页数：11
相关论文
共 37 条
  • [31] 血清FAM19A5、IL-34在血管性认知障碍患者中的表达及临床意义
    张永慧
    孙咏捷
    郝喜娃
    梁芙茹
    李月春
    [J]. 疑难病杂志, 2024, 23 (09) : 1060 - 1064+1069
  • [32] Impacts of a 12-week aerobic, resistance, and combined exercise training on serum FAM19A5, glucose homeostasis, and novel cardiovascular risk factors among adults with obesity
    Mir, Ehsan
    Shamseddini, Alireza
    Rahimi, Najmeh
    Bazgir, Behzad
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024,
  • [33] 血清FAM19A5、vitronectin对冠心病合并心力衰竭患者冠状动脉病变程度及主要不良心血管事件的评估价值
    陈博婷
    崔莹雪
    郭小艳
    [J]. 国际检验医学杂志, 2025, 46 (02) : 191 - 195+200
  • [34] Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease
    Deng, Hui
    Xu, Honglan
    Luo, Yuxuan
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (07) : 123 - 128
  • [35] Upregulated LncRNA H19 Sponges MiR-106a-5p and Contributes to Aldosterone-Induced Vascular Calcification via Activating the Runx2-Dependent Pathway
    Li, Xiong-Zhi
    Xiong, Zhuo-Chao
    Zhang, Shao-Ling
    Hao, Qing-Yun
    Liu, Zhao-Yu
    Zhang, Hai-Feng
    Wang, Jing-Feng
    Gao, Jing-Wei
    Liu, Pin-Ming
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (09) : 1684 - 1699
  • [36] Exploring the Association between Depression, Suicidality, and Serum Brain-Derived Neurotrophic Factor, FAM19A5, Total Antioxidant Status, Total Oxidant Status, Oxidative Stress Index, and Cytokine Levels: A Case-Control Study of Drug-Naive Adolescents with First-Episode Major Depressive Disorder
    Cakir, Aylin Deniz Uzun
    Cakir, Burak
    Sapmaz, Sermin Yalin
    Bilac, Oznur
    Taneli, Fatma
    Kandemir, Hasan
    [J]. PSYCHOPATHOLOGY, 2024,
  • [37] 5-Hydroxytryptamine induces cyclooxygenase-2 in rat vascular smooth muscle cells: Mechanisms involving Src, PKC and MAPK activation (vol 656, pg 19, 2011)
    Machida, Takuji
    Ohta, Misa
    Onoguchi, Akina
    Iizuka, Kenji
    Sakai, Mio
    Minami, Masaru
    Hirafuji, Masahiko
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 303 - 303
1234